Genome-wide detection of enhancer-hijacking events from chromatin interaction data in rearranged genomes.

Nature Methods
Xiaotao WangFeng Yue

Abstract

Recent efforts have shown that structural variations (SVs) can disrupt three-dimensional genome organization and induce enhancer hijacking, yet no computational tools exist to identify such events from chromatin interaction data. Here, we develop NeoLoopFinder, a computational framework to identify the chromatin interactions induced by SVs, including interchromosomal translocations, large deletions and inversions. Our framework can automatically resolve complex SVs, reconstruct local Hi-C maps surrounding the breakpoints, normalize copy number variation and allele effects and predict chromatin loops induced by SVs. We applied NeoLoopFinder in Hi-C data from 50 cancer cell lines and primary tumors and identified tens of recurrent genes associated with enhancer hijacking. To experimentally validate NeoLoopFinder, we deleted the hijacked enhancers in prostate adenocarcinoma cells using CRISPR-Cas9, which significantly reduced expression of the target oncogene. In summary, NeoLoopFinder enables identification of critical oncogenic regulatory elements that can potentially reveal therapeutic targets.

References

Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
Oct 15, 2010·Nature Biotechnology·Bradley E BernsteinJames A Thomson
Sep 4, 2012·Nature Methods·Maxim ImakaevLeonid A Mirny
Sep 8, 2012·Nature·UNKNOWN ENCODE Project Consortium
Feb 7, 2014·Genome Research·Ferhat AyWilliam Stafford Noble
Jul 22, 2014·Nature·Paul A NorthcottStefan M Pfister
Oct 27, 2015·Proceedings of the National Academy of Sciences of the United States of America·Adrian L SanbornErez Lieberman Aiden
Feb 2, 2016·Nature Genetics·Yotam DrierBradley E Bernstein
Apr 16, 2016·Nucleic Acids Research·Fidel RamírezThomas Manke
May 5, 2016·Nucleic Acids Research·Maxim V KuleshovAvi Ma'ayan
May 24, 2016·Cell Reports·Geoffrey FudenbergLeonid A Mirny
Jun 14, 2016·Cell Reports·Jennifer M SpangleMyles Brown
Aug 18, 2016·Bioinformatics·Hua-Jun Wu, Franziska Michor
Jul 21, 2017·Nature·Paul A NorthcottPeter Lichter
Feb 3, 2018·Nucleic Acids Research·Enrique VidalGuillaume J Filion
Apr 26, 2018·Nature Reviews. Genetics·Malte SpielmannStefan Mundlos
Sep 8, 2018·BMC Bioinformatics·Nicolas ServantJean-Philippe Vert
Sep 12, 2018·Nature Genetics·Jesse R DixonFeng Yue
Sep 29, 2018·Nature Genetics·Bjørt K KragesteenGuillaume Andrey
Jun 30, 2019·Frontiers in Oncology·Camille DerderianOlorunseun O Ogunwobi
Nov 2, 2019·Cancer Cell·Victor QueredaDerek R Duckett
Jul 11, 2020·Nature Communications·Tarik J SalamehFeng Yue

❮ Previous
Next ❯

Software Mentioned

cooler
EnrichR
BWA MEM
calCB
runHiC
- FREEC
FitHiC2
pyBigWig
mathop
Hi

Related Concepts

Related Feeds

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.